Commentary on: L-methylfolate, methylcobolamine, and N-acetylcysteine in the treatment of Alzheimer's disease-related cognitive decline.
Cummings
Jeffrey L
JL
Department of Neurology and Psychiatry, David Geffen School of Medicine, University of California, Los Angeles, USA.
D000111:Acetylcysteine / Q000627:therapeutic use*; D000544:Alzheimer Disease / Q000150:complications*; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology*; D016166:Free Radical Scavengers / Q000627:therapeutic use*; D006801:Humans; D013763:Tetrahydrofolates / Q000627:therapeutic use*; D014805:Vitamin B 12 / Q000031:analogs & derivatives* / Q000627:therapeutic use
D016166:Free Radical Scavengers; D013763:Tetrahydrofolates; C019476:mecobalamin; D014805:Vitamin B 12; C005984:5-methyltetrahydrofolate; D000111:Acetylcysteine